跳至主要内容
临床试验/NCT02569749
NCT02569749终止不适用

Sleep Apnea-Hypopnea Syndrome Screening

Arrhythmia Network Technology S.L.9 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
15
试验地点
9
主要终点
Percentage of patients with SAHS in patients with ICD or CRTD therapy

研究概览

简要总结

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • No previous diagnosis of sleep apnea
  • Fulfilling at least one of the following:
  • Pacemaker indication
  • ICD or CRTD therapy indication
  • Heart failure and preserved LVEF (40-50%)
  • Heart failure and reduced LVEF (<40%)
  • Signed informed consent

排除标准

  • Age younger than 18 years
  • Renal hemodialysis
  • Cardiac transplant indication
  • Women who are pregnant
  • Advanced cancer
  • Enrollment in another investigational study
  • Able and willing to comply with all testing and requirements
  • Patient not suitable for inclusion due to psychiatric conditions or short life expectancy

结局指标

主要结局

Percentage of patients with SAHS in patients with ICD or CRTD therapy

时间窗: 1 month

Percentage of patients with SAHS in patients with reduced LVEF

时间窗: 1 month

Percentage of patients with SAHS in patients with pacemaker indication

时间窗: 1 month

Percentage of patients with SAHS in patients with heart failure and preserved LVEF

时间窗: 1 month

次要结局

  • Percentage of patients with central sleep apnea in all groups(1 month)
  • Percentage of patients with obstructive sleep apnea in all groups(1 month)

研究者

发起方
Arrhythmia Network Technology S.L.
申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验